← back to search

Xiaoqiu Liu

UNSW Sydney · AU
Area of research
Infectious Diseases · Surgery
Research interest
Research focused on Tuberculosis and Placebo, with related work in Directly Observed Therapy, Pill, Medication adherence. Notable publications include 'Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial', 'Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial', and 'Temporal Factors and Missed Doses of Tuberculosis Treatment. A Causal Associations Approach to Analyses of Digital Adherence Data'.
h-index
citations
504
works
9
NIH funding
primary concept
email

Recent publications

Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial
The Lancet 2024cited by 37position: middledoi
Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trial
The Lancet 2024cited by 37position: middledoi
Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of Hypertension
Journal of the American College of Cardiology 2024cited by 32position: middledoi
Traditional Chinese Medicine for the Treatment of Acute Intracerebral Haemorrhage: A Multicentre, Randomised, Placebo-Controlled, Double-Blind, Clinical Trial
SSRN Electronic Journal 2024cited by 0position: middledoi
Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial
The Lancet Global Health 2023cited by 59position: firstdoi
Effectiveness of a Comprehensive Package Based on Electronic Medication Monitors at Improving Treatment Outcomes Among Tuberculosis Patients in Tibet: A Multi-Centre Randomised Controlled Trial
SSRN Electronic Journal 2023cited by 12position: middledoi
Temporal Factors and Missed Doses of Tuberculosis Treatment. A Causal Associations Approach to Analyses of Digital Adherence Data
Annals of the American Thoracic Society 2019cited by 38position: middledoi
Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trial
Trials 2018cited by 32position: middledoi
Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial
PLoS Medicine 2015cited by 257position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Katherine Fielding · Austin Hospital4 papers (2015–2023) · 4 papers (2015–2023) · 3 papers (2015–2023) · 2 papers (2018–2023)Sedona Sweeney · London School of Hygiene & Tropical Medicine2 papers (2018–2023)Hui Zhang · Shihezi University2 papers (2015–2023) · 2 papers (2018–2023)Dongmei Hu · Guangzhou University of Chinese Medicine2 papers (2018–2023) · 2 papers (2015–2019)Xiaomeng Wang · Nanjing University of Chinese Medicine1 papers (2023–2023) · 1 papers (2024–2024)Suzanne Oparil · University of Alabama at Birmingham1 papers (2024–2024) · 1 papers (2018–2018)Christopher Gianacas · UNSW Sydney1 papers (2024–2024)William C. Cushman · University of Tennessee Health Science Center1 papers (2024–2024)Diederick E. Grobbee · Sint Franciscus Gasthuis1 papers (2024–2024)Wilko Spiering · Utrecht University1 papers (2024–2024)JA Thompson · London School of Hygiene & Tropical Medicine1 papers (2023–2023)Anthony Rodgers · Tropical Population Health Unit1 papers (2024–2024)Dike Ojji · University of Cape Town1 papers (2024–2024)